Literature DB >> 30249702

Getting Our Fingers on the Pulse of Slow-Growing Bacteria in Hard-To-Reach Places.

Tara Gallagher1, Joann Phan1, Katrine Whiteson2.   

Abstract

Chronic infections with slow-growing pathogens have plagued humans throughout history. However, assessing the identities and growth rates of bacteria in an infection has remained an elusive goal. Neubauer et al. (J. Bacteriol. 200:e00365-18, 2018, https://doi.org/10.1128/JB.00365-18) combine two cutting-edge approaches to make progress on both fronts: probing specific RNA molecules to assess the identity of actively transcribing microbes and measuring growth rates through incorporation of stable isotope labels. They found that growth rates of pathogens were relatively stable during antibacterial therapy. The article delves into a basic and unanswered question that gets to the heart of understanding infection: what are the microbial growth rates?
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  Staphylococcus aureus; cystic fibrosis; fatty acids; growth modeling; stable isotope

Mesh:

Substances:

Year:  2018        PMID: 30249702      PMCID: PMC6256019          DOI: 10.1128/JB.00540-18

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  44 in total

1.  Microbial determinants of biochemical individuality and their impact on toxicology and pharmacology.

Authors:  Andrew D Patterson; Peter J Turnbaugh
Journal:  Cell Metab       Date:  2014-08-21       Impact factor: 27.287

2.  Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients.

Authors:  Dieter Worlitzsch; Robert Tarran; Martina Ulrich; Ute Schwab; Aynur Cekici; Keith C Meyer; Peter Birrer; Gabriel Bellon; Jürgen Berger; Tilo Weiss; Konrad Botzenhart; James R Yankaskas; Scott Randell; Richard C Boucher; Gerd Döring
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

3.  Does bacterial density in cystic fibrosis sputum increase prior to pulmonary exacerbation?

Authors:  Franziska A Stressmann; Geraint B Rogers; Peter Marsh; Andrew K Lilley; Thomas W V Daniels; Mary P Carroll; Lucas R Hoffman; Graeme Jones; Collette E Allen; Nilesh Patel; Benjamin Forbes; Andrew Tuck; Kenneth D Bruce
Journal:  J Cyst Fibros       Date:  2011-06-12       Impact factor: 5.482

4.  Trace incorporation of heavy water reveals slow and heterogeneous pathogen growth rates in cystic fibrosis sputum.

Authors:  Sebastian H Kopf; Alex L Sessions; Elise S Cowley; Carmen Reyes; Lindsey Van Sambeek; Yang Hu; Victoria J Orphan; Roberta Kato; Dianne K Newman
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-29       Impact factor: 11.205

5.  Cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology.

Authors:  Kelli L Palmer; Lauren M Mashburn; Pradeep K Singh; Marvin Whiteley
Journal:  J Bacteriol       Date:  2005-08       Impact factor: 3.490

6.  A Winogradsky-based culture system shows an association between microbial fermentation and cystic fibrosis exacerbation.

Authors:  Robert A Quinn; Katrine Whiteson; Yan-Wei Lim; Peter Salamon; Barbara Bailey; Simone Mienardi; Savannah E Sanchez; Don Blake; Doug Conrad; Forest Rohwer
Journal:  ISME J       Date:  2015-03-17       Impact factor: 10.302

7.  Phenazine content in the cystic fibrosis respiratory tract negatively correlates with lung function and microbial complexity.

Authors:  Ryan C Hunter; Vanja Klepac-Ceraj; Magen M Lorenzi; Hannah Grotzinger; Thomas R Martin; Dianne K Newman
Journal:  Am J Respir Cell Mol Biol       Date:  2012-08-03       Impact factor: 6.914

8.  Identification of Fitness Determinants during Energy-Limited Growth Arrest in Pseudomonas aeruginosa.

Authors:  David W Basta; Megan Bergkessel; Dianne K Newman
Journal:  mBio       Date:  2017-11-28       Impact factor: 7.867

9.  Pediatric Cystic Fibrosis Sputum Can Be Chemically Dynamic, Anoxic, and Extremely Reduced Due to Hydrogen Sulfide Formation.

Authors:  Elise S Cowley; Sebastian H Kopf; Alejandro LaRiviere; Wiebke Ziebis; Dianne K Newman
Journal:  MBio       Date:  2015-07-28       Impact factor: 7.867

10.  Evidence and Role for Bacterial Mucin Degradation in Cystic Fibrosis Airway Disease.

Authors:  Jeffrey M Flynn; David Niccum; Jordan M Dunitz; Ryan C Hunter
Journal:  PLoS Pathog       Date:  2016-08-22       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.